ACTION AGAINST AGE-RELATED MACULAR DEGENERATION
ACTION AGAINST AGE RELATED MACULAR DEGENERATION ('AAAMD') WILL FACILITATE FUND RAISING FOR BIOMEDICAL RESEARCH INTO THE TREATMENT OF AMD AND BE A DATA SOURCE OF RELATED INFORMATION. AAAMD IS AN EQUAL COLLABORATION BETWEEN BLIND VETERANS UK, FIGHT FOR SIGHT, MACULAR SOCIETY AND THE SCOTTISH WAR BLINDED. THE EXISTING CHARITABLE ACTIVITIES OF THE FOUNDERS WILL CONTINUE ALONGSIDE AAAMD.
Latest income
£122k
Latest spending
£407k
Registered
2016
Accounts read
FY2025
Financial health, per its FY2025 accounts
The accounts state that the group reported a net deficit of £61,395 for the year ended 31 March 2025, driven by total expenditure of £407,257 against income of £121,763. However, the trustees confirm the charity has adequate resources to continue as a going concern, supported by cash reserves of £463,309 and unrestricted reserves of £283,249 at the charity level.
What the accounts disclose
Highest-paid employee band: £150,001 - £160,000 — above the 90th percentile for charities its size (median £60k)
“Employee(s) received emoluments within the band £150,001 to £160,000” — page 25
Per its FY2025 accounts as filed with the Charity Commission.
Reserves policy: six months of expected core cost expenditure (held: £283k)
“AAAMD’s reserve policy is set at six months of expected core cost expenditure. For 2024/2025 this has been calculated at £111,544”
Per its FY2025 accounts as filed with the Charity Commission.
Payments to trustees: Antonius Rijnders received £6,000 through the trading subsidiary for services provided to the subsidiary's operations.
“During the period, Antonius Rijnders (a charity trustee, and a non-executive director of the charity’s trading subsidiary, Foresight Research Limited, company number 12048839), was paid a total sum of £6,000 (2024: £6,000) through the trading subsidiary for services provided to the subsidiary’s operations.” — page 29
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Donation from Sight Scotland Veterans
“During the year, the charity received £nil (2024: £77,000) from Sight Scotland Veterans and £100,000 from Macular Society (2024: £100,000). This represents the last instalment of three annual unrestricted financial contributions (totalling £300,000) payable by June 2024 following the amendment to the Collaboration Agreement dated 8th February 2018.” — page 29
“During the year, the charity received £nil (2024: £77,000) from Sight Scotland Veterans and £100,000 from Macular Society (2024: £100,000). This represents the last instalment of three annual unrestricted financial contributions (totalling £300,000) payable by June 2024 following the amendment to the Collaboration Agreement dated 8th February 2018.” — page 29
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Donation from Macular Society
“During the year, the charity received £nil (2024: £77,000) from Sight Scotland Veterans and £100,000 from Macular Society (2024: £100,000). This represents the last instalment of three annual unrestricted financial contributions (totalling £300,000) payable by June 2024 following the amendment to the Collaboration Agreement dated 8th February 2018.” — page 29
“During the year, the charity received £nil (2024: £77,000) from Sight Scotland Veterans and £100,000 from Macular Society (2024: £100,000). This represents the last instalment of three annual unrestricted financial contributions (totalling £300,000) payable by June 2024 following the amendment to the Collaboration Agreement dated 8th February 2018.” — page 29
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: PRI Loan from Sight Scotland Veterans
“During the year, the charity received £nil (2024: £77,000) from Sight Scotland Veterans and £100,000 from Macular Society (2024: £100,000). This represents the last instalment of three annual unrestricted financial contributions (totalling £300,000) payable by June 2024 following the amendment to the Collaboration Agreement dated 8th February 2018.” — page 29
“During the year, the charity received £nil (2024: £77,000) from Sight Scotland Veterans and £100,000 from Macular Society (2024: £100,000). This represents the last instalment of three annual unrestricted financial contributions (totalling £300,000) payable by June 2024 following the amendment to the Collaboration Agreement dated 8th February 2018.” — page 29
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Trustee remuneration via subsidiary
“During the year, the charity received £nil (2024: £77,000) from Sight Scotland Veterans and £100,000 from Macular Society (2024: £100,000). This represents the last instalment of three annual unrestricted financial contributions (totalling £300,000) payable by June 2024 following the amendment to the Collaboration Agreement dated 8th February 2018.” — page 29
“During the year, the charity received £nil (2024: £77,000) from Sight Scotland Veterans and £100,000 from Macular Society (2024: £100,000). This represents the last instalment of three annual unrestricted financial contributions (totalling £300,000) payable by June 2024 following the amendment to the Collaboration Agreement dated 8th February 2018.” — page 29
Per its FY2025 accounts as filed with the Charity Commission.
Trading subsidiary: Foresight Research Limited, Foresight Research Scotland Limited
“AAAMD has two subsidiaries. Foresight Research Limited (FRL, a trading Private limited company incorporated in the UK on 13th June 2019, Company registration number: 12048839) and Foresight Research Scotland Limited (a dormant Private limited company incorporated in Scotland on 14th June 2019 company registration number: 633501).” — page 3
Per its FY2025 accounts as filed with the Charity Commission.
Corporate structure
- Trading subsidiary: FORESIGHT RESEARCH LIMITED Companies House 12048839
- Trading subsidiary: FORESIGHT RESEARCH SCOTLAND LIMITED Companies House SC633501
FORESIGHT RESEARCH SCOTLAND LIMITED — per its own Companies House accounts
- Issued share capital consists of 100 Ordinary Shares of £1 each, held by the parent charity.
FORESIGHT RESEARCH LIMITED — per its own Companies House accounts
- Profit before tax: £-208k
- The company has received £500,000 as a Programme Related Investment (loan) from several charities, which is unsecured, has no fixed repayment schedule, and is only repayable if certain turnover or profitability levels are achieved.
Trustees
- Mark O'Donnellchair
- Adrian Bell
- CATHERINE MARY YELF
- Craig Douglas Spalding
- Dr Antonius Rijnders
- Edward James Holloway
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £122k | £407k |
| 31/03/2024 | £291k | £443k |
| 31/03/2023 | £354k | £356k |
| 31/03/2022 | £350k | £306k |
| 31/03/2021 | £211k | £313k |
Common questions
Is ACTION AGAINST AGE-RELATED MACULAR DEGENERATION financially healthy?
Per its FY2025 accounts: The accounts state that the group reported a net deficit of £61,395 for the year ended 31 March 2025, driven by total expenditure of £407,257 against income of £121,763. However, the trustees confirm the charity has adequate resources to continue as a going concern, supported by cash reserves of £463,309 and unrestricted reserves of £283,249 at the charity level. Its FY2025 accounts were audited by Wenn Townsend.
What does the highest-paid employee of ACTION AGAINST AGE-RELATED MACULAR DEGENERATION earn?
Per its FY2025 accounts, the highest-paid employee was in the £150,001 - £160,000 band.
Who funds ACTION AGAINST AGE-RELATED MACULAR DEGENERATION?
Funders whose own accounts filings name ACTION AGAINST AGE-RELATED MACULAR DEGENERATION as a grant recipient include SCHRODER CHARITY TRUST.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| SCHRODER CHARITY TRUST | FY2024 | £5k |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE IAN ASKEW CHARITABLE TRUST | 2 | £2k |
| THE ARCHITECTURAL ASSOCIATION FOUNDATION | 1 | £1.0m |
| THE ALBERT GUBAY CHARITABLE FOUNDATION | 1 | £254k |
| ROBERT LUFF FOUNDATION LIMITED | 1 | £170k |
| THE HEARN FOUNDATION | 1 | £100k |
| DELVES CHARITABLE TRUST | 1 | £65k |
| THE LINBURY TRUST | 1 | £65k |
| THE HAREBELL CENTENARY FUND | 1 | £40k |
Charities like this
- THE MACULAR DISEASE SOCIETY
- FOUNDATION OF THE SOCIETY OF RETINA SPECIALISTS
- BRACE
- AMR Action UK
- AMMF - THE CHOLANGIOCARCINOMA CHARITY
- BRISTOL DEMENTIA ACTION ALLIANCE (BDAA)
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| ACTION AGAINST AGE-RELATED MACULAR DEGENERATION | £122k | £150,001 - £160,000 | — | above | — | no doubt |
| THE MACULAR DISEASE SOCIETY | £8.9m | — | — | above | — | no doubt |
| FOUNDATION OF THE SOCIETY OF RETINA SPECIALISTS | £2.7m | €100,001 - €110,000 | — | above | — | no doubt |
| BRACE | £644k | — | 0 | above | 11.0% | no doubt |
| AMR Action UK | £407k | — | 0 | unclear | — | no doubt |
| AMMF - THE CHOLANGIOCARCINOMA CHARITY | £1.0m | — | 0 | above | — | no doubt |